Oticara

1 known investors

Oticara is a clinical-stage biopharmaceutical company developing an investigational intranasal corticosteroid therapy for chronic rhinosinusitis (CRS). Its product is a single-dose, semisolid emulsion formulation placed by an ENT physician under endoscopic guidance, targeting patients with persistent symptoms after topical therapies and sinus surgery.

BiotechMedical Devices